Palogic Value Management’s Pfizer PFE Stock Holding History

Palogic Value Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-8,815	Closed	-$223K	–	171
2025 Q1	$223K	Hold	8,815	–	–	0.1%	140
2024 Q4	$234K	Sell	8,815 -10	-0.1%	-$271	0.09%	150
2024 Q3	$255K	Hold	8,825	–	–	0.09%	154
2024 Q2	$247K	Hold	8,825	–	–	0.1%	138
2024 Q1	$245K	Hold	8,825	–	–	0.11%	140
2023 Q4	$254K	Hold	8,825	–	–	0.11%	135
2023 Q3	$293K	Buy	8,825 +10	+0.1%	+$354	0.14%	124
2023 Q2	$323K	Hold	8,815	–	–	0.15%	122
2023 Q1	$360K	Hold	8,815	–	–	0.18%	123
2022 Q4	$452K	Buy	+8,815	New	+$423K	0.24%	101

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Palogic Value Management's PFE Position: Q2 2025 in Review

Palogic Value Management sold out of Pfizer (PFE) in Q2 2025, closing a stake of 8,815 shares — an estimated $223K sold.

Palogic Value Management first reported a position in PFE in Q4 2022 and held it in 10 quarters. The position peaked at $452K in Q4 2022. 2,810 funds tracked by Wall St. Rank hold PFE as of Q2 2025.

Palogic Value Management reported no remaining Pfizer position as of Q2 2025 after selling out during the quarter.
Palogic Value Management sold 8,815 Pfizer shares in Q2 2025, an estimated $223K.
Palogic Value Management first reported a position in Pfizer in Q4 2022 and held it in 10 quarters.
Palogic Value Management's Pfizer position peaked at $452K in Q4 2022.
2,810 funds tracked by Wall St. Rank held Pfizer as of Q2 2025.

Based on Palogic Value Management's 13F filing for Q2 2025, filed 5 Aug 2025.